Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
827.54
+9.52 (1.16%)
Apr 22, 2025, 4:00 PM EDT - Market closed
Eli Lilly Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Eli Lilly stock have an average target of 1,020, with a low estimate of 840 and a high estimate of 1,190. The average target predicts an increase of 23.30% from the current stock price of 827.54.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eli Lilly stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 11 | 12 | 12 | 12 | 12 | 10 |
Buy | 9 | 9 | 8 | 8 | 7 | 7 |
Hold | 2 | 2 | 2 | 2 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 22 | 23 | 22 | 22 | 20 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $975 | Buy | Initiates | $975 | +17.82% | Apr 22, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $973 → $928 | Strong Buy | Maintains | $973 → $928 | +12.14% | Apr 14, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $1,146 → $1,124 | Buy | Maintains | $1,146 → $1,124 | +35.82% | Apr 9, 2025 |
Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $892 → $888 | Hold → Strong Buy | Upgrades | $892 → $888 | +7.31% | Apr 8, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $970 → $1,100 | Buy | Maintains | $970 → $1,100 | +32.92% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
60.13B
from 45.04B
Increased by 33.50%
Revenue Next Year
71.80B
from 60.13B
Increased by 19.40%
EPS This Year
23.18
from 11.71
Increased by 97.93%
EPS Next Year
29.92
from 23.18
Increased by 29.09%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 64.2B | 82.5B | 96.5B | ||
Avg | 60.1B | 71.8B | 84.0B | ||
Low | 56.9B | 64.0B | 74.8B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 42.5% | 37.2% | 34.3% | ||
Avg | 33.5% | 19.4% | 17.0% | ||
Low | 26.3% | 6.4% | 4.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 25.13 | 36.44 | 45.85 | ||
Avg | 23.18 | 29.92 | 37.19 | ||
Low | 21.11 | 26.55 | 30.60 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 114.6% | 57.2% | 53.3% | ||
Avg | 97.9% | 29.1% | 24.3% | ||
Low | 80.3% | 14.5% | 2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.